Stoke Therapeutics to Present Updates on RNA-Based Medicines at 25th Annual Needham Virtual Healthcare Conference

Stoke Therapeutics has announced its participation in the 25th Annual Needham Virtual Healthcare Conference. The company, which focuses on developing RNA-based medicines to address genetic diseases, is scheduled to present at the event. The presentation will provide updates on Stoke’s ongoing research and development efforts.

The conference, a prominent gathering for healthcare professionals and industry leaders, will take place virtually. Stoke Therapeutics plans to share insights into its pipeline of investigational therapies, including progress in clinical trials and advancements in its proprietary technology platform. Further details about the specific timing of the presentation or topics covered have not been disclosed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI